Showing 731-740 of 3082 results for "".
Remote Work Balances Life
https://practicalneurology.com/columns/practice-management/remote-work-balances-life/30354/Clarification of Call Coverage: Always a Duty of Neurologists
https://practicalneurology.com/columns/practice-management/PN0809_06-php/30897/New Diagnostic Tool Approved for Evaluation of Dementia Patients
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/new-diagnostic-tool-approved-for-evaluation-of-dementia-patients/30778/Amyvid, which indicates levels of beta-amyloid plaques in the brain, can help guide the diagnosis of dementia.Impaired Driving Related to Medications and Neurological Diagnoses
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/impaired-driving-related-to-medications-and-neurological-diagnoses/30686/Researchers investigated the degree to which various common agents, including benzodiazepines and non-benzodiazepine hypnotics, may affect driving ability. Therapy selection and patient counseling are key to safe use.Exploring Expanded Labeling for DBS for Parkinson's
https://practicalneurology.com/diseases-diagnoses/movement-disorders/exploring-expanded-labeling-for-dbs-for-parkinsons/30694/Expanded labeling is based on data showing an improvement in quality of life and longer-term data.Pathway to Success? MS Drug Takes Nrf-2 Pathway for Treatment
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/pathway-to-success-ms-drug-takes-nrf-2-pathway-for-treatment/30774/BG-12 is an oral therapy under regulatory review in the US and Europe for the treatment of MS.Special Report: A Touching Movement
https://practicalneurology.com/diseases-diagnoses/tbi/special-report-a-touching-movement/30642/A quadriplegic man moved neuromodulation a step forward.Treating Early Relapsing Multiple Sclerosis: Induction & Escalation Approaches
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/treating-early-relapsing-multiple-sclerosis-induction-escalation-approaches/31873/Evidence-based clinical trial results are needed to guide this difficult decision-making processDementia Insights: The World Turned Upside Down:
July 2023—A Remarkable Month in the World of Alzheimer Disease Diagnosis and Treatmenthttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-the-world-turned-upside-downbrjuly-2023-a-remarkable-month-in-the-world-of-alzheimer-disease-diagnosis-and-treatment/32075/A review of recent drug approvals, policy changes, and significant studies in the field.Antisense Oligonucleotide Therapies
https://practicalneurology.com/diseases-diagnoses/movement-disorders/antisense-oligonucleotide-therapies/31573/Antisense oligonucleotides are a promising new therapeutic class being studied for the treatment of movement disorders.